Indivior PLCNASDAQ:INDV
- LAST PRICE15.8600
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots16.2900/ 2
- Ask / Lots16.3200/ 7
- Open / Previous Close0.0000 / 15.8600
- Day Range---
- 52 Week Range
- Volume793
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | INDV |
|---|---|---|
| 09:32 ET | 1495 | 16.18 |
| 09:36 ET | 700 | 16.05 |
| 09:39 ET | 1392 | 16.07 |
| 09:45 ET | 1100 | 16.11 |
| 09:52 ET | 100 | 16.1 |
| 09:56 ET | 100 | 16.12 |
| 10:03 ET | 100 | 16.08 |
| 10:15 ET | 100 | 16.06 |
| 10:19 ET | 700 | 16.05 |
| 10:24 ET | 100 | 16.1 |
| 10:26 ET | 100 | 16.105 |
| 10:32 ET | 924 | 16.09 |
| 10:39 ET | 100 | 16.07 |
| 10:42 ET | 106 | 16.05 |
| 10:46 ET | 1001 | 16.05 |
| 10:50 ET | 700 | 16.03 |
| 10:55 ET | 7557 | 16.025 |
| 10:57 ET | 1674 | 16.04 |
| 11:00 ET | 2000 | 16.02 |
| 11:06 ET | 300 | 16.025 |
| 11:11 ET | 1300 | 16 |
| 11:13 ET | 200 | 16.05 |
| 11:22 ET | 100 | 16.03 |
| 11:27 ET | 100 | 16.03 |
| 11:29 ET | 400 | 16.03 |
| 11:45 ET | 300 | 16.01 |
| 11:56 ET | 600 | 16.04 |
| 12:00 ET | 100 | 16.02 |
| 12:07 ET | 100 | 16.0001 |
| 12:12 ET | 1051 | 15.98 |
| 12:32 ET | 7224 | 16.025 |
| 12:34 ET | 900 | 16.04 |
| 12:36 ET | 100 | 16.03 |
| 12:38 ET | 300 | 16.035 |
| 12:54 ET | 200 | 16.02 |
| 12:59 ET | 200 | 16 |
| 01:01 ET | 320 | 16.01 |
| 01:06 ET | 100 | 15.98 |
| 01:15 ET | 3152 | 15.98 |
| 01:21 ET | 100 | 15.95 |
| 01:32 ET | 100 | 15.96 |
| 01:37 ET | 200 | 15.95 |
| 01:42 ET | 500 | 15.94 |
| 01:57 ET | 300 | 15.96 |
| 02:02 ET | 340 | 15.94 |
| 02:04 ET | 930 | 15.89 |
| 02:09 ET | 300 | 15.9 |
| 02:13 ET | 100 | 15.92 |
| 02:20 ET | 301 | 15.905 |
| 02:26 ET | 400 | 15.92 |
| 02:29 ET | 500 | 15.905 |
| 02:31 ET | 158 | 15.93 |
| 02:36 ET | 100 | 15.9 |
| 02:54 ET | 300 | 15.9037 |
| 03:00 ET | 100 | 15.92 |
| 03:02 ET | 550 | 15.91 |
| 03:09 ET | 400 | 15.9 |
| 03:12 ET | 840 | 15.88 |
| 03:23 ET | 501 | 15.89 |
| 03:25 ET | 100 | 15.899 |
| 03:27 ET | 100 | 15.9 |
| 03:30 ET | 200 | 15.9 |
| 03:36 ET | 100 | 15.89 |
| 03:38 ET | 1400 | 15.9 |
| 03:39 ET | 400 | 15.89 |
| 03:41 ET | 700 | 15.89 |
| 03:43 ET | 600 | 15.86 |
| 03:45 ET | 1612 | 15.895 |
| 03:50 ET | 100 | 15.9 |
| 03:52 ET | 300 | 15.9 |
| 03:54 ET | 400 | 15.89 |
| 03:56 ET | 9181 | 15.9 |
| 03:57 ET | 1220 | 15.85 |
| 03:59 ET | 2251 | 15.86 |
Jun 18, 2024
Indivior Announces the Publication of New Data on the Comparative Effectiveness of Intranasal (IN) Nalmefene (OPVEE 2.7mg) and IN Naloxone (4 mg) in a Translational Model Assessing the Impact of a Synthetic Opioid Overdose on Respiratory Depression and Cardiac Arrest, from 3:40PM ET on Tuesday Jun 18, 2024 by Dow Jones
3:40PM ET on Tuesday Jun 18, 2024 by Dow Jones
Jun 10, 2024
May 23, 2024
*DJ Indivior: Resolution Set out in Notice of Meeting Was Duly Passed by Shareholders, from 8:30AM ET on Thursday May 23, 2024 by Dow Jones
8:30AM ET on Thursday May 23, 2024 by Dow JonesIndivior to Host Analyst Teach-in Event in New York City; Reconfirms Full Year 2024 Guidance, from 7:02AM ET on Thursday May 23, 2024 by Dow Jones
7:02AM ET on Thursday May 23, 2024 by Dow Jones*DJ Indivior PLC Backs View, from 7:00AM ET on Thursday May 23, 2024 by Dow Jones
7:00AM ET on Thursday May 23, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Indivior PLC | 1.7B | 401.7x | --- |
Company Information
Indivior PLC is a pharmaceutical company. The Company develops medicines to treat addiction and serious mental illnesses. The Company focuses on building a portfolio of opioid dependence treatments. It has a pipeline of product candidates designed to address other chronic conditions and co-occurring disorders of addiction, including alcohol use disorder. Its product pipeline focuses on development and discovery of non-opioid treatment strategies for opioid use disorder (OUD), as well as therapies to address the needs of people suffering from alcohol, stimulant, and cannabis use disorders. Its Sublocade, Subutex, and Suboxone are used for the treatment of opioid use disorder (OUD). Perseris is used for the treatment of Schizophrenia. The Company's pipeline products include AEF0117, INDV-2000, INDV-1000, RBP-6000, RBP-7000, Buprenorphine Sublingual and Naloxone Film, and Buprenorphine and Naloxone Sublingual Tablet. Its pipeline also includes the Orexin-1 Receptor Antagonist Program.
Contact Information
- Headquarters
- 10710 Midlothian Turnpike Suite 125, North ChesterfieldCHESTERFIELD, VA, United States 23235
- Phone
- 804-379-1090
- Fax
- ---
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.7B |
|---|---|
Revenue (TTM) | $884.6M |
Shares Outstanding | 134.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.16 |
EPS | $-0.02 |
Book Value | $0.00 |
P/E Ratio | 401.7x |
Price/Sales (TTM) | 1.9 |
Price/Cash Flow (TTM) | 67.6x |
Operating Margin | 0.36% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
